Jianjun Wang

Dr. Jianjun Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
CHChun Huang
Chun Huang
YFYuan Fang
Yuan Fang
FYFeng Yan
Feng Yan
TWTao Wang
Tao Wang
CDCai Dong-Bin
Cai Dong-Bin
JWJianjun Wang
Jianjun Wang
Introduction Late-life depression (LLD) is a global public health issue, often accompanied by cognitive impairments that can exacerbate the severity of depression and impair social functioning. Despite being a well-established treatment for LLD, the suitability of problem-solving therapy (PST) for individuals with LLD and varying degrees of cognitive impairments warrants further investigation. This paper presents the protocol for a systematic review and meta-analysis of randomised controlled trials (RCTs) aimed at evaluating the effectiveness and acceptability of PST for this specific demographic. Methods/analysis Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we will conduct a systematic review to synthesise existing research on PST for individuals in this demographic. We will comprehensively search multiple databases and sources, including PubMed, EMBASE, the Cochrane Database and APA PsycNET from inception to October 2023, without language, publication year or type restrictions. Relevant studies will be manually screened from the references. Only RCTs involving PST for LLD will be included. The primary efficacy outcome will be the standardised mean difference in total scores on continuous depression severity scales across different comparison arms. Data extraction will be conducted independently by two reviewers (CH and J-JW), and methodological rigour will be assessed using the Cochrane Risk of Bias assessment tool. Subgroup and sensitivity analyses will be performed to investigate the impact of concomitant cognitive impairments and to evaluate the robustness of the findings. Ethics and dissemination The meta-analysis project is expected to be ethically unproblematic and does not require approval from a research ethics committee. The results of this study will be shared through articles in scholarly peer-reviewed journals and presentations in various formats, both print and digital. PROSPERO registration number CRD42023473782

16 June 2022 in Frontiers in Neurology
Verified
Journal Article
Open access
FKFanxin Kong
Fanxin Kong
HZHaotao Zheng
Haotao Zheng
XLXuan Liu
Xuan Liu
SLSongjun Lin
Songjun Lin
JWJianjun Wang
Jianjun Wang
ZGZhouke Guo
Zhouke Guo
Leukoencephalopathy with vanishing white matter (LVWM) is an autosomal recessive disease. Ovarioleukodystrophy is defined as LVWM in females showing signs or symptoms of gradual ovarian failure. We present a 38-year-old female with ovarioleukodystrophy who showed status epilepticus, gait instability, slurred speech, abdominal tendon hyperreflexia, and ovarian failure. Abnormal EEG, characteristic magnetic resonance, and unreported EIF2B5 compound heterozygous mutations [c.1016G>A (p.R339Q) and c.1157G>A (p.G386D)] were found. Furthermore, the present report summarizes 20 female patients with adult-onset ovarioleukodystrophy and EIF2B5 gene mutations. In conclusion, a new genetic locus for LVWM was discovered. Compared with previous cases, mutations at different EIF2B5 sites might have different clinical manifestations and obvious clinical heterogeneity.

17 September 2024 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
LHLiyu Hu
Liyu Hu
JCJianxiang Chen
Jianxiang Chen
XLXinbei Li
Xinbei Li
HZHaoran Zhang
Haoran Zhang
JZJinhuan Zhang
Jinhuan Zhang
JXJinping Xu
Jinping Xu
Background: Although depression symptoms are commonly reported in patients with subcortical vascular mild cognitive impairment (svMCI), their impact on brain functions remains largely unknown, with diagnoses mainly dependent on behavioral assessments.Methods: In this study, we analyzed resting-state fMRI data from a cohort of 34 svMCI patients, comprising 18 patients with depression symptoms (svMCI+D) and 16 patients without (svMCI-D), along with 34 normal controls (NC). The study used the fraction of the amplitude of low-frequency fluctuations (fALFF), resting-state functional connectivity, correlation analyses, and support vector machine (SVM) techniques.Results: The fALFF of the right cerebellum (CERE.R) differed among the svMCI+D, svMCI-D, and NC groups. Specifically, the regional mean fALFF of CERE. R was lower in svMCI-D patients compared to NC but higher in svMCI+D patients compared to svMCI-D patients. Moreover, the adjusted fALFF of CERE. R showed a significant correlation with Montreal Cognitive Assessment (MOCA) scores in svMCI-D patients. The fALFF of the right orbital part of the superior frontal gyrus was significantly correlated with Hamilton Depression Scale scores in svMCI+D patients, whereas the fALFF of the right postcingulate cortex (PCC.R) showed a significant correlation with MOCA scores in svMCI-D patients. Furthermore, RSFC between PCC. R and right precuneus, as well as between CERE. R and the right lingual gyrus (LING.R), was significantly reduced in svMCI-D patients compared to NC. In regional analyses, the adjusted RSFC between PCC. R and PreCUN. R, as well as between CERE. R and LING. R, was decreased in svMCI-D patients compared to NC but increased in svMCI+D patients compared to svMCI-D. Further SVM analyses achieved good performances, with an area under the curve (AUC) of 0.82 for classifying svMCI+D, svMCI-D, and NC; 0.96 for classifying svMCI+D and svMCI-D; 0.82 for classifying svMCI+D and NC; and 0.92 for classifying svMCI-D and NC.Conclusion: The study revealed disruptive effects of cognitive impairment, along with both disruptive and complementary effects of depression symptoms on spontaneous brain activity in svMCI. Moreover, these findings suggest that the identified features might serve as potential biomarkers for distinguishing between svMCI+D, svMCI-D, and NC, thereby guiding clinical treatments such as transcranial magnetic stimulation for svMCI.

25 July 2026 in International Psychogeriatrics
Verified
Journal Article
Open access
XLXinbei Li
Xinbei Li
YLYingqi Lu
Yingqi Lu
JCJianxiang Chen
Jianxiang Chen
QQQiuYang Qian
QiuYang Qian
YWYue Wang
Yue Wang
HLHANQING LYU
HANQING LYU
Subcortical vascular mild cognitive impairment (svMCI) is an early stage of cognitive decline, frequently accompanied by emotional disturbances like depressive symptoms. While previous studies have explored cognitive and emotional symptoms in svMCI, research on the associated brain functional changes remains limited. Dynamic functional magnetic resonance imaging (fMRI) provides a novel approach to examining temporal variability in brain activity, offering insights into dynamic neural function changes. This study aims to investigate alterations in dynamic fMRI metrics in svMCI patients and analyze their relationships with cognitive function and depressive symptom. This study enrolled 116 patients with svMCI (60 with depressive symptoms (svMCI+D) and 56 without depressive symptoms (svMCI-D)) and 36 healthy controls (HC). All participants underwent resting-state functional magnetic resonance imaging (fMRI). Dynamic amplitude of low-frequency fluctuations (dALFF), dynamic fractional ALFF (dfALFF), and dynamic regional homogeneity (dReHo) were calculated as key indices. Group differences were tested using one-way analysis of covariance (ANCOVA) with age and gender as covariates, followed by post hoc two-sample t-tests for pairwise comparisons. Partial correlation analyses examined associations between dynamic metrics and cognitive performance (MMSE and MoCA) as well as affective symptoms (HAMD and HAMA). Mediation analyses were then conducted to further probe potential pathways linking altered brain dynamics to clinical measures. Compared with HC, both the svMCI + D and svMCI-D showed significantly reduced dALFF in several regions, including the left lingual gyrus, left superior temporal gyrus, left cuneus, and right paracentral lobule. In addition, the svMCI + D group exhibited increased dALFF in the right hippocampus. The svMCI-D group showed lower dALFF in the left gyrus rectus and left cuneus. For dReHo, the svMCI + D group demonstrated higher values in the right cingulate gyrus and adjacent cortex, along with lower values in the left thalamus and left inferior frontal gyrus. These altered dynamic measures were positively correlated with depressive severity and negatively correlated with cognitive performance. The study showed that patients with svMCI, especially those with depressive symptoms, exhibited significant alterations in dynamic fMRI metrics across multiple brain regions. These changes were associated with cognitive performance and depressive symptom severity. Dynamic measures, including dALFF and dReHo, provide neurobiological markers to better characterize cognitive and emotional disturbances in svMCI.

18 September 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
LCLiling Chen
Liling Chen
XJXinyu Jia
Xinyu Jia
JWJianjun Wang
Jianjun Wang
LLLiling Li
Liling Li
JCJianxiang Chen
Jianxiang Chen
HLHanqing Lyu
Hanqing Lyu
Background: Major depressive disorder (MDD) is a complex and heterogeneous condition. Current diagnosis relies on symptom-based assessments, leading to varied treatment responses. Data-driven approaches have attempted to identify MDD subtypes, but their clinical applicability remains limited. Traditional Chinese Medicine (TCM) provides a theory-driven classification system that categorizes MDD into syndrome subtypes of deficiency pattern and excess pattern, offering insights into the biological mechanisms and personalized treatment strategies. Objective: This systematic review and meta-analysis aims to identify potential neurobiological distinctions of TCM-based deficiency and excess patterns in MDD by examining differences in the brain activity by using various functional magnetic resonance imaging (fMRI) modalities, including resting-state and task-based fMRI, diffusion tensor imaging, and magnetic resonance spectroscopy. Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P), we will conduct a comprehensive search of 7 electronic databases (PubMed, Embase, Web of Science, Chinese Biological Medical Literature database, China National Knowledge Infrastructure, Chinese Wanfang database, and Chongqing VIP database) for studies published up to December 2024. Eligible studies will be screened by 2 independent reviewers based on predefined inclusion criteria, followed by data extraction and quality assessment. For the meta-analysis, resting-state fMRI studies will be analyzed in Montreal Neurological Institute space using Seed-based d Mapping-Permutation of Subject Images software (version 6.21), enabling a focused evaluation of brain activity differences in deficiency and excess MDD patterns. Results: The search and screening for the systematic literature review were completed in December 2024. This study relies on published, publicly accessible data. We found approximately 30 eligible studies in our preliminary search, suggesting that a quantitative meta-analysis is feasible. Data extraction, quality appraisal, and subsequent data synthesis will begin in September 2025. The review should be completed by December 2025, and the study results will be published in 2026. Conclusions: The results of this study may help to explain the neural mechanisms of depression’s neurobiological subtypes from the perspective of TCM. Trial Registration: PROSPERO CRD42023475178; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023475178 International Registered Report Identifier (IRRID): DERR1-10.2196/68996

20 November 2024 in JMIR Preprints
Verified
Preprint
Open access
LCLiling Chen
Liling Chen
XJXinyu Jia
Xinyu Jia
JWJianjun Wang
Jianjun Wang
LLLiling Li
Liling Li
JCJianxiang Chen
Jianxiang Chen
HLHanqing Lyu
Hanqing Lyu
BACKGROUND Major depressive disorder (MDD) is a complex and heterogeneous condition. Current diagnosis relies on symptom-based assessments, leading to varied treatment responses. Data-driven approaches have attempted to identify MDD subtypes, but their clinical applicability remains limited. Traditional Chinese Medicine (TCM) provides a theory-driven classification system that categorizes MDD into syndrome subtypes of deficiency pattern and excess pattern, offering insights into the biological mechanisms and personalized treatment strategies. OBJECTIVE This systematic review and meta-analysis aims to identify potential neurobiological distinctions of TCM-based deficiency and excess patterns in MDD by examining differences in the brain activity by using various functional magnetic resonance imaging (fMRI) modalities, including resting-state and task-based fMRI, diffusion tensor imaging, and magnetic resonance spectroscopy. METHODS In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P), we will conduct a comprehensive search of 7 electronic databases (PubMed, Embase, Web of Science, Chinese Biological Medical Literature database, China National Knowledge Infrastructure, Chinese Wanfang database, and Chongqing VIP database) for studies published up to December 2024. Eligible studies will be screened by 2 independent reviewers based on predefined inclusion criteria, followed by data extraction and quality assessment. For the meta-analysis, resting-state fMRI studies will be analyzed in Montreal Neurological Institute space using Seed-based d Mapping-Permutation of Subject Images software (version 6.21), enabling a focused evaluation of brain activity differences in deficiency and excess MDD patterns. RESULTS The search and screening for the systematic literature review were completed in December 2024. This study relies on published, publicly accessible data. We found approximately 30 eligible studies in our preliminary search, suggesting that a quantitative meta-analysis is feasible. Data extraction, quality appraisal, and subsequent data synthesis will begin in September 2025. The review should be completed by December 2025, and the study results will be published in 2026. CONCLUSIONS The results of this study may help to explain the neural mechanisms of depression’s neurobiological subtypes from the perspective of TCM. CLINICALTRIAL PROSPERO CRD42023475178; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023475178 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/68996